$Moderna (MRNA.US)$ "Shares of Moderna (MRNA) jumped more than 10% shortly after 6 p.m. ET, after the company announced a deal to supply the US government with 100 million doses of its Covid-19 vaccine candidate currently in late-stage human trials."  This is a big deal.

$Remark Holdings (MARK.US)$
Schools reopening under controversy since COVID-19 numbers still high. Flu season around the corner. Schools and other reopening sectors will need to exhaust all precautions, including REMARK's AI thermal kits.